| 1. |
- Salazar-Alvarez, German, et al.
(författare)
-
Synthesis and nonlinear light scattering of microemulsions and nanoparticle suspensions
- 2007
-
Ingår i: Journal of nanoparticle research. - : Springer Science and Business Media LLC. - 1388-0764 .- 1572-896X. ; 9:4, s. 647-652
-
Tidskriftsartikel (refereegranskat)abstract
- Microemulsions composed of normal or inverse micellar solutions and aqueous suspensions of pristine (uncoated) or silica-coated iron oxide nanoparticles, mainly gamma-Fe2O3, were synthesised and their optical limiting properties investigated. The microemulsions are colorless solutions with high transparency for visible wavelengths while the aqueous suspensions of iron oxide are of pale yellow colour. Optical limiting experiments performed in 2 mm cells using a f/5 optical system with a frequency doubled Nd:YAG laser delivering 5 ns pulses with 10 Hz repetition rate, showed clamping levels of similar to 3 mu J for the suspensions of both pristine and silica-coated iron oxide nanoparticles. A strong photoinduced nonlinear light scattering was observed for the water-in-oil microemulsion and the aqueous suspensions of nanoparticles while oil-in-water microemulsions did not show a significant nonlinear effect. Measurements carried out using an integrating sphere further verified that the photoinduced nonlinear light scattering is the dominating nonlinear mechanism while the nonlinear absorption of iron oxide nanoparticles is negligible at 532 nm.
|
|
| 2. |
- Wallin, Anders, 1950, et al.
(författare)
-
Donepezil in Alzheimer's disease : What to expect after 3 years of treatment in a routine clinical setting
- 2007
-
Ingår i: Dementia and Geriatric Cognitive Disorders. - Basel : S. Karger AG. - 1420-8008 .- 1421-9824. ; 23:3, s. 150-160
-
Tidskriftsartikel (refereegranskat)abstract
- Background/Aims: Clinical short-term trails have shown positive effects of donepezil treatment in patients with Alzheimer's disease. The outcome of continuous long-term treatment in the routine clinical settings remains to be investigated. Methods: The Swedish Alzheimer Treatment Study (SATS) is a descriptive, prospective, longitudinal, multicentre study. Four hundred and thirty-five outpatients with the clinical diagnosis of Alzheimer's disease, received treatment with donepezil. Patients were assessed with Mini-Mental State Examination (MMSE), Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog), global rating (CIBIC) and Instrumental Activities of Daily Living (IADL) at baseline and every 6 months for a total period of 3 years. Results: The mean MMSE change from baseline was positive for more than 6 months and in subgroups of patients for 12 months. After 3 years of treatment the mean change from baseline in MMSE-score was 3.8 points (95% CI, 3.0-4.7) and the ADAS-cog rise was 8.2 points (95% CI, 6.4-10.1). This is better than expected in untreated historical cohorts, and better than the ADAS-cog rise calculated by the Stern equation (15.6 points, 95% CI, 14.5-16.6). After 3 years with 38% of the patients remaining, 30% of the them were unchanged or improved in the global assessment. Conclusion: Three-year donepezil treatment showed a positive global and cognitive outcome in the routine clinical setting. Copyright © 2007 S. Karger AG.
|
|
